Haemonetics (HAE) said its second-quarter net income rose to $18.05 million or $0.69 per share from $14.81 million or $0.57 per share in the comparable period. Non-GAAP net income for the latest quarter grew to $18.05 million or $0.69 per share from $15.01 million or $0.58 per share last year. On average, 8 analysts polled by Thomson Reuters expected earnings per share of $0.65 for the quarter. Analysts' estimate typically excludes one-time items.
Net revenues for the second quarter increased 7.6% to $157.07 million from $145.92 million last year. Six analysts estimated revenues of $157.84 million. Haemonetics expects full-year Platelet revenue growth in a range of 0-2%. The company confirmed its full-year guidance of 8-11% revenue growth and earnings per share in a range of $2.75 - $2.85. Eight analysts expect earnings per share of $2.81 for the full year.
For comments and feedback: editorial@rttnews.com